Carthagenetics

Carthagenetics is a leading business consulting and services provider, specializing in supporting companies dedicated to developing treatments for rare diseases and orphan drugs. With a rich history dating back to its founding in 2004, CarthaGenetics® offers unparalleled expertise in navigating complex European markets, including Turkey, and the expanding North African region.

Located at Chemin de Rennier, Le Milléis, Pully, Vaud 1009, CH, CarthaGenetics® leverages its deep understanding of the rare disease landscape to offer strategic market access, early access programs, and clinical trial support. The company's comprehensive services facilitate regulatory pathway navigation, pricing and reimbursement planning, and stakeholder mapping, ensuring that innovative medicines reach the patients who need them most. CarthaGenetics® also maintains offices in Carthage Centre, Rue du Lac de Constance, Les Berges du Lac, 1053, TN; Tour Algeria Business Center 11eme étage, Les Pins Maritimes, Algiers, DZ; Kozyatağı Mahallesi, Değirmen Sokak, Nidakule No: 18/19 B, Kat: 10, Kadıköy, Istanbul, TR; Regus, Seestern Prinzenallee 7, Prinzenpark 3. und 5, Düsseldorf, NRW 40549, DE; Cuzco IV, Paseo de Castellana 141, Madrid, Madrid 28046, ES; Le Périscope, 83 /87 avenue d'Italie, Paris , 75013, FR; and RNL, via Caradosso 18, (MI) Italy, Milano, MI 20123, IT.

Carthagenetics is committed to excellence and innovation in the rare disease treatment space. The company's dedication to improving patient access and its collaborative approach make it a trusted partner for biotech and pharmaceutical companies worldwide. CarthaGenetics® continues to expand its reach and impact, ensuring that more patients have access to life-changing therapies. We invite the manager of CarthaGenetics to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and commercial development.